Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Valero Energy Corporation (VLO) - free report >>
icad inc. (ICAD) - free report >>
PetIQ, Inc. (PETQ) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Valero Energy Corporation (VLO) - free report >>
icad inc. (ICAD) - free report >>
PetIQ, Inc. (PETQ) - free report >>
Image: Shutterstock
New Strong Sell Stocks for August 11th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Fastly, Inc. (FSLY - Free Report) operates an edge cloud platform for processing, serving, and securing its customer's applications. The Zacks Consensus Estimate for its current year earnings has been revised 47.5% downward over the last 30 days.
Largo Resources Ltd. (LGO - Free Report) operates as a natural resource development and exploration company. The Zacks Consensus Estimate for its current year earnings has been revised 7.3% downward over the last 30 days.
PetIQ, Inc. (PETQ - Free Report) operates as a pet medication and wellness company. The Zacks Consensus Estimate for its current year earnings has been revised 10.6% downward over the last 30 days.
Valero Energy Corporation (VLO - Free Report) manufactures, markets, and sells transportation fuels and petrochemical products. The Zacks Consensus Estimate for its current year earnings has been revised 61.5% downward over the last 30 days.
iCAD, Inc. (ICAD - Free Report) provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.